Home > Neurophage Pharmaceuticals Salary

Neurophage Pharmaceuticals Salary

  • 91
  • 62
  • 100
Neurophage Pharmaceuticals average salary is $88,774, median salary is $94,160 with a salary range from $67,870 to $104,291.
Neurophage Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Neurophage Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 3 Neurophage Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Embedded Software Engineer 67,870-67,870 West Sacramento, CA, 95605 2015 Neurophage Pharmaceuticals Embedded Software Engineer Salaries (1)
Neurophage Pharmaceuticals West Sacramento, CA Salaries
Marketing Manager 104,291-104,291 West Sacramento, CA, 95605 2013 Neurophage Pharmaceuticals Marketing Manager Salaries (1)
Neurophage Pharmaceuticals West Sacramento, CA Salaries
Computer Software Developer 94,160-94,160 West Sacramento, CA, 95605 2012 Neurophage Pharmaceuticals Computer Software Developer Salaries (1)
Neurophage Pharmaceuticals West Sacramento, CA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Neurophage Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Neurophage Pharmaceuticals Jobs
See more Neurophage Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Neurophage Pharmaceuti... Information
  • NeuroPhage Pharmaceuticals
  • Industry: BioTech/Drugs
  • City: Cambridge, MA
  • NeuroPhage is developing a breakthrough protein dissaggregation platform for treatment of neurodegenerative diseases. Our lead Alzheimer¡¯s disease (AD) drug candidate, NPT001, safely and effectively dissaggregates existing Aa plaque in preclinical animal models, which is unique among disease-modifying approaches for AD.